Please login to the form below

Not currently logged in
Email:
Password:

Aveo

This page shows the latest Aveo news and features for those working in and with pharma, biotech and healthcare.

Relay Therapeutics strengthens team

Relay Therapeutics strengthens team

He has held roles for Keryx Biopharmaceutical, Algeta ASA and AVEO Oncology.

Latest news

  • NICE backs EUSA's RCC treatment Fotivda NICE backs EUSA's RCC treatment Fotivda

    cases. EUSA licenced Fotivda from Aveo Pharmaceuticals back in 2015, but although it has European approval in advanced renal cell carcinoma it failed to gain approval from the US Food and ... However, Aveo Oncology is looking to re-file Fotivda in the

  • Samsung Bioepis wins CHMP nod for second Humira biosimilar Samsung Bioepis wins CHMP nod for second Humira biosimilar

    Tivozanib - originally developed by Aveo Pharma - was turned down by the FDA in 2013.

  • Novartis licenses cancer support drug from Aveo Oncology Novartis licenses cancer support drug from Aveo Oncology

    Novartis licenses cancer support drug from Aveo Oncology. Swiss firm buys into drug to alleviate a wasting syndrome that is seen in chronic patients. ... Novartis is paying up to $326m to license rights to a drug developed by Aveo Oncology designed to

  • FDA turns down tivozanib for kidney cancer FDA turns down tivozanib for kidney cancer

    FDA turns down tivozanib for kidney cancer. Agency describes data provided by Aveo Oncology and Astellas as "uninterpretable". ... while Aveo announced a major restructuring of its operations last week which included a refocusing of its R&D on tivozanib

  • Regulatory struggles force Aveo to cut 140 jobs Regulatory struggles force Aveo to cut 140 jobs

    Regulatory struggles force Aveo to cut 140 jobs. Expects FDA rejection for tivozanib in kidney cancer. ... bringing to a halt Aveo's plans for the drug in the condition. “

More from news
Approximately 3 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2016 Deal Watch March 2016

    Collaboration – marketing &distribution. $171. AVEO Oncology/ CANbridge Life Sciences. AV-203; ErbB3 (HER3) inhibitory antibody for oesophageal cancer.

  • Deal Watch December 2015 Deal Watch December 2015

    405. Aveo (US). EUSA. Collaboration, licence. Pre-registration tivozanib for renal cell carcinoma.

  • Pharma deals in August 2015 Pharma deals in August 2015

    Another early stage deal [opportunities do not seem to hang around long!] was that between Novartis and Aveo where Novartis paid an upfront fee of $15m to secure rights to AV ... Collaboration extension. 330. Aveo. Novartis. AV 380 antibody for

  • Deal Watch table for November 2014 Deal Watch table for November 2014

    Acquisition of voucher. 125. AVEO Oncology / Ophthotech Corporation. VEGF tyrosine kinase inhibitor tivozanib.

  • Pharma deals during February 2014 Pharma deals during February 2014

    In another termination of an oncology deal, Astellas exercised its right to terminate its collaboration with Aveo Oncology to develop the tyrosine kinase inhibitor, tivozanib, for “ strategic reasons”.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance

    He joins the biopharma from Tang Capital Management. AVEO Oncology has appointed Dr Nikhil Mehta as senior vice president or regulatory and quality assurance, a role that will see him oversee ... I anticipate Dr Mehta’s integration into the AVEO team

  • AVEO's financial head joins ImmunoGen AVEO's financial head joins ImmunoGen

    David Johnston has left his role as chief financial officer of AVEO Pharmaceuticals to join ImmunoGen in the same role. ... Johnston's switch comes after more than six years at AVEO having joined the company from his role as senior VP of finance

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics